BIOMAT Database Logo BIOMAT Database Logo

COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice? 2020

Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
Department of Pharmacology, All India Institute of Medical Sciences, Raipur, India. Electronic address: drpugal23@gmail.com.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
COVID-19 Second Wave in India - Wait or Act?
November 2021, The American journal of medicine,
Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
Do we have a choice?
August 1998, Archives of psychiatric nursing,
Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
Living with the COVID-19 pandemic: act now with the tools we have.
October 2020, Lancet (London, England),
Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
[How long do we have to wait?].
March 1978, Vardfacket,
Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing?
January 2024, Journal of internal medicine,
Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
Coccygectomy for coccygodynia: do we really have to wait?
July 2008, Injury,
Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
Coccygectomy for coccygodynia: do we really have to wait?
October 2007, Injury,
Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
Now we know the drug of first choice--or do we?
January 2007, Epilepsy currents,
Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
June 2020, The journal of the Royal College of Physicians of Edinburgh,
Pugazhenthan Thangaraju, and Meenalotchini Prakash Gurunthalingam, and Sajitha Venkatesan, and Eswaran Thangaraju
Workforce literacy: do we have a choice?
January 1991, Journal of healthcare materiel management,
Copied contents to your clipboard!